JP2022513111A5 - - Google Patents
Info
- Publication number
- JP2022513111A5 JP2022513111A5 JP2021528936A JP2021528936A JP2022513111A5 JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5 JP 2021528936 A JP2021528936 A JP 2021528936A JP 2021528936 A JP2021528936 A JP 2021528936A JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna
- sequence
- group
- ids
- sequence ids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306562 | 2018-11-23 | ||
| EP18306562.2 | 2018-11-23 | ||
| PCT/EP2019/082216 WO2020104649A2 (en) | 2018-11-23 | 2019-11-22 | Novel rna compositions and methods for inhibiting angptl8 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513111A JP2022513111A (ja) | 2022-02-07 |
| JP2022513111A5 true JP2022513111A5 (cg-RX-API-DMAC7.html) | 2022-11-29 |
| JP7707065B2 JP7707065B2 (ja) | 2025-07-14 |
Family
ID=64564803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021528936A Active JP7707065B2 (ja) | 2018-11-23 | 2019-11-22 | Angptl8を阻害するための新規のrna組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12416004B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3884051A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7707065B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113166760A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020104649A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166760A (zh) | 2018-11-23 | 2021-07-23 | 赛诺菲 | 用于抑制angptl8的新型rna组合物和方法 |
| US20220372063A1 (en) * | 2019-09-05 | 2022-11-24 | Sanofi | Oligonucleotides containing nucleotide analogs |
| PE20250353A1 (es) * | 2021-06-24 | 2025-02-06 | Lilly Co Eli | Terapeutica con arn novedosos y usos de estos |
| WO2024138111A1 (en) | 2022-12-23 | 2024-06-27 | Eli Lilly And Company | Novel rna therapeutics and uses thereof |
| WO2024160147A1 (zh) * | 2023-02-01 | 2024-08-08 | 北京福元医药股份有限公司 | 抑制血管生成素样蛋白8基因表达的siRNA、其缀合物和药物组合物及用途 |
| WO2024227059A2 (en) * | 2023-04-27 | 2024-10-31 | Aligos Therapeutics, Inc. | Short interfering nucleic acid (sina) molecules targeting angptl 3 and angptl 8 and methods of using the same |
| WO2025264952A2 (en) | 2024-06-21 | 2025-12-26 | Eli Lilly And Company | Novel rna therapeutics and uses thereof |
| CN119367545B (zh) * | 2025-01-02 | 2025-04-08 | 山东第一医科大学(山东省医学科学院) | 靶向干预ANGPTL8 mRNA在制备治疗高同型半胱氨酸血症药物中的应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5665710A (en) | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6054299A (en) | 1994-04-29 | 2000-04-25 | Conrad; Charles A. | Stem-loop cloning vector and method |
| JP4335310B2 (ja) | 1995-06-07 | 2009-09-30 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用 |
| US5981501A (en) | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
| US7422902B1 (en) | 1995-06-07 | 2008-09-09 | The University Of British Columbia | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| ATE237312T1 (de) | 1998-07-20 | 2003-05-15 | Protiva Biotherapeutics Inc | In liposomen verkapselte nukleinsäurekomplexe |
| BR9914772A (pt) | 1998-10-09 | 2001-12-11 | Ingene Inc | Conjunto de elementos genéticos, vetor, célulahospedeira, conjunto para a produção de umasequência de ácido nucléico, método para aprodução in vivo ou in vitro de uma sequência deácido nucléico, transcrição de cdna, molécula deácido nucléico inibidor, transcrição de mrna,molécula heteroduplex e composiçãofarmacêutica |
| AU6298899A (en) | 1998-10-09 | 2000-05-01 | Ingene, Inc. | Production of ssdna (in vivo) |
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| CN101583346B (zh) | 2006-04-28 | 2015-08-19 | 儿童医院医疗中心 | 用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质 |
| CN101500548A (zh) | 2006-08-18 | 2009-08-05 | 弗·哈夫曼-拉罗切有限公司 | 用于体内递送多核苷酸的多缀合物 |
| EP2319926B1 (en) | 2007-07-05 | 2016-08-31 | Arrowhead Research Corporation | DSRNA for treating viral infection |
| EP2229186A2 (en) | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| WO2010093788A2 (en) | 2009-02-11 | 2010-08-19 | Dicerna Pharmaceuticals, Inc. | Multiplex dicer substrate rna interference molecules having joining sequences |
| EP4253395A3 (en) * | 2012-08-06 | 2023-11-29 | Alnylam Pharmaceuticals, Inc. | Processes for the preparation of carbohydrate conjugated rna agents |
| PL2992098T3 (pl) | 2013-05-01 | 2019-09-30 | Ionis Pharmaceuticals, Inc. | Kompozycje i sposoby modulowania ekspresji hbv i ttr |
| PL3439689T3 (pl) | 2016-04-08 | 2022-01-31 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia hiperlipidemii inhibitorem angptl8 i inhibitorem angptl3 |
| CN112105625B (zh) | 2018-03-07 | 2024-12-31 | 赛诺菲 | 核苷酸前体、核苷酸类似物以及含其的寡聚化合物 |
| CN113166760A (zh) | 2018-11-23 | 2021-07-23 | 赛诺菲 | 用于抑制angptl8的新型rna组合物和方法 |
| CN115176011B (zh) | 2019-08-27 | 2025-11-11 | 赛诺菲 | 用于抑制pcsk9的组合物和方法 |
| US20220372063A1 (en) | 2019-09-05 | 2022-11-24 | Sanofi | Oligonucleotides containing nucleotide analogs |
| US20230383294A1 (en) | 2020-10-16 | 2023-11-30 | Sanofi | Novel rna compositions and methods for inhibiting angptl3 |
| EP4229201A1 (en) | 2020-10-16 | 2023-08-23 | Sanofi | Rna compositions and methods for inhibiting lipoprotein(a) |
| US20240092819A1 (en) | 2020-10-20 | 2024-03-21 | Sanofi | Novel ligands for asialoglycoprotein receptor |
-
2019
- 2019-11-22 CN CN201980077074.6A patent/CN113166760A/zh active Pending
- 2019-11-22 EP EP19805337.3A patent/EP3884051A2/en active Pending
- 2019-11-22 WO PCT/EP2019/082216 patent/WO2020104649A2/en not_active Ceased
- 2019-11-22 JP JP2021528936A patent/JP7707065B2/ja active Active
- 2019-11-22 US US17/296,530 patent/US12416004B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546040A5 (cg-RX-API-DMAC7.html) | ||
| JP2022547888A5 (cg-RX-API-DMAC7.html) | ||
| JP2019530656A5 (cg-RX-API-DMAC7.html) | ||
| JP7249080B2 (ja) | 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用 | |
| TWI680767B (zh) | 用於增強的細胞攝取之化合物及方法 | |
| JP2021533804A5 (cg-RX-API-DMAC7.html) | ||
| HRP20200672T1 (hr) | RNAi SREDSTVA, PRIPRAVCI I POSTUPCI NJIHOVE UPOTREBE ZA LIJEČENJE BOLESTI POVEZANIH S TRANSTIRETINOM (TTZ) | |
| ES2753174T3 (es) | Métodos de tratamiento de Síndrome de Alport | |
| JP2021517126A5 (cg-RX-API-DMAC7.html) | ||
| FI4426270T3 (fi) | Lipidi-nanopartikkelit oligonukleotidien kuljetusta varten | |
| JP2017532038A5 (cg-RX-API-DMAC7.html) | ||
| AU2013235691B2 (en) | Boronic acid conjugates of oligonucleotide analogues | |
| JP2017525705A5 (cg-RX-API-DMAC7.html) | ||
| IL316808A (en) | Modified double-stranded RNA materials and their uses | |
| JP2021503941A5 (cg-RX-API-DMAC7.html) | ||
| RU2020135289A (ru) | Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в | |
| RU2011127079A (ru) | Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с | |
| CA3057561A1 (en) | Rna interference mediated inhibition of tmprss6 | |
| RU2020115761A (ru) | МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В | |
| JP2022533419A5 (cg-RX-API-DMAC7.html) | ||
| CN103492569A (zh) | 碱基经修饰的寡核苷酸 | |
| JP2002534433A (ja) | プロトン付加または酸性化された核酸および使用法 | |
| JP2024530956A5 (cg-RX-API-DMAC7.html) | ||
| CN115702006A (zh) | 缀合基团及其缀合物 | |
| JPWO2021125311A5 (cg-RX-API-DMAC7.html) |